Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension

Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved..

OBJECTIVES: This study sought to evaluate cardiac baroreflex sensitivity (BRS) as a predictor of response to renal sympathetic denervation (RDN).

BACKGROUND: Catheter-based RDN is a novel treatment option for patients with resistant arterial hypertension. It is assumed that RDN reduces efferent renal and central sympathetic activity.

METHODS: Fifty patients (age 60.3 ± 13.8 years [mean ± SD mean systolic blood pressure (BP) on ambulatory blood pressure monitoring (ABPM) 157 ± 22 mm Hg, despite medication with 5.4 ± 1.4 antihypertensive drugs) underwent RDN. Prior to RDN, a 30-min recording of continuous arterial BP (Finapres; TNO-TPD Biomedical Instrumentation, Amsterdam, the Netherlands) and high-resolution electrocardiography (1.6 kHz in orthogonal XYZ leads) was performed in all patients under standardized conditions. Cardiac BRS was assessed by phase-rectified signal averaging (BRSPRSA) according to previously published technologies. Response to RDN was defined as a reduction of mean systolic BP on ABPM by 10 mm Hg or more at 6 months after RDN.

RESULTS: Six months after RDN, mean systolic BP on ABPM was significantly reduced from 157 ± 22 mm Hg to 149 ± 20 mm Hg (p = 0.003). Twenty-six of the 50 patients (52%) were classified as responders. BRSPRSA was significantly lower in responders than nonresponders (0.16 ± 0.75 ms/mm Hg vs. 1.54 ± 1.73 ms/mm Hg; p < 0.001). Receiver-operator characteristics analysis revealed an area under the curve for prediction of response to RDN by BRSPRSA of 81.2% (95% confidence interval: 70.0% to 90.1%; p < 0.001). On multivariable logistic regression analysis, reduced BRSPRSA was the strongest predictor of response to RDN, which was independent of all other variables tested.

CONCLUSIONS: Impaired cardiac BRS identifies patients with resistant hypertension who respond to RDN.

Errataetall:

CommentIn: J Am Coll Cardiol. 2013 Dec 3;62(22):2131-3. - PMID 23973687

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:62

Enthalten in:

Journal of the American College of Cardiology - 62(2013), 22 vom: 03. Dez., Seite 2124-30

Sprache:

Englisch

Beteiligte Personen:

Zuern, Christine S [VerfasserIn]
Eick, Christian [VerfasserIn]
Rizas, Konstantinos D [VerfasserIn]
Bauer, Sarah [VerfasserIn]
Langer, Harald [VerfasserIn]
Gawaz, Meinrad [VerfasserIn]
Bauer, Axel [VerfasserIn]

Links:

Volltext

Themen:

ABPM
AIC
AUC
Akaike information criterion
Ambulatory blood pressure monitoring
Area under the curve
Arterial hypertension
BMI
BP
BRS
BRS(PRSA)
BRS(SEQ)
Baroreflex sensitivity
Blood pressure
Body mass index
CI
Cardiac baroreflex sensitivity assessed by phase-rectified signal averaging
Cardiac baroreflex sensitivity assessed by the sequence method
Confidence interval
IDI
Integrated discrimination improvement
Journal Article
MSNA
Muscle sympathetic nerve activity
PRSA
Phase-rectified signal averaging
RDN
ROC
Receiver-operator characteristic
Renal sympathetic denervation
Sympathetic nervous system

Anmerkungen:

Date Completed 17.02.2014

Date Revised 19.08.2014

published: Print-Electronic

CommentIn: J Am Coll Cardiol. 2013 Dec 3;62(22):2131-3. - PMID 23973687

Citation Status MEDLINE

doi:

10.1016/j.jacc.2013.07.046

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM230295614